Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 1:57 PM
Ignite Modification Date: 2025-12-25 @ 12:45 PM
NCT ID: NCT01287195
Description: The safety population included all participants who received at least one dose of study medication.
Frequency Threshold: 0
Time Frame: From baseline up to Week 10
Study: NCT01287195
Study Brief: Oral OKT3 for the Treatment of Active Ulcerative Colitis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Oral OKT3 Participants with ulcerative colitis received 1 mg Oral OKT3 given with 20 mg oral Omeprazole once daily for 30 days. 0 None 2 6 1 6 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Ulcerative colitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Anorectal abscess SYSTEMATIC_ASSESSMENT Infections and infestations None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Periorbital edema SYSTEMATIC_ASSESSMENT Eye disorders None View